A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.
Saved in:
| Title: | A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients. |
|---|---|
| Authors: | Gasser O; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Sharples KJ; Dunedin School of Medicine, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Barrow C; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Williams GM; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand., Bauer E; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Wood CE; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Mester B; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand., Dzhelali M; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Caygill G; GlycoSyn, PO Box 31 310, Lower Hutt, 5040, New Zealand., Jones J; GlycoSyn, PO Box 31 310, Lower Hutt, 5040, New Zealand., Hayman CM; The Ferrier Research Institute, Victoria University of Wellington, PO Box 33436, Lower Hutt, 5046, New Zealand., Hinder VA; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Macapagal J; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., McCusker M; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Weinkove R; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand.; Capital and Coast District Health Board, Private Bag 7902, Wellington, 6242, New Zealand., Painter GF; The Ferrier Research Institute, Victoria University of Wellington, PO Box 33436, Lower Hutt, 5046, New Zealand., Brimble MA; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand., Findlay MP; Cancer Trials New Zealand, University of Auckland, Private Bag 92019, Auckland, 1142, New Zealand., Dunbar PR; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand.; School of Biological Sciences, University of Auckland, PO Box 92019, Auckland, New Zealand., Hermans IF; Malaghan Institute of Medical Research, PO Box 7060, Wellington, 6242, New Zealand. ihermans@malaghan.org.nz.; Maurice Wilkins Centre for Molecular Biodiscovery, Private Bag 92019, Auckland, 1142, New Zealand. ihermans@malaghan.org.nz.; School of Biological Sciences, Victoria University of Wellington, PO Box 600, Wellington, 6140, New Zealand. ihermans@malaghan.org.nz. |
| Source: | Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2018 Feb; Vol. 67 (2), pp. 285-298. Date of Electronic Publication: 2017 Nov 01. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Springer Verlag Country of Publication: Germany NLM ID: 8605732 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0851 (Electronic) Linking ISSN: 03407004 NLM ISO Abbreviation: Cancer Immunol Immunother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
